Edwards Lifesciences Corp

EW: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
sX!LOCK|VcT<?LOCK|d>Vqlvl

Edwards Lifesciences Earnings: Solid Growth Boosted by Transcatheter Mitral Valve Therapy Sales

After selling its critical care business, Edwards posted third-quarter results that featured 10% constant currency revenue growth from the remaining heart valve portfolio.

Sponsor Center